Industry, Civil Society Groups Frustrated Over TRIPS Compromise

By Jessica Karins / June 21, 2022 at 7:00 PM
Groups with a variety of views on tweaking aspects of the Trade-Related Aspects of Intellectual Property Rights Agreement for COVID-19 vaccines can agree on one thing: They’re unhappy with the compromise outcome produced by the World Trade Organization at its 12th ministerial last week. The American Enterprise Institute on Tuesday hosted a panel discussion titled “The Debate over Intellectual Property Protections for COVID-19 Vaccines after one year,” which featured discontented responses from both sides of the TRIPS question. “I think...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.